Diabetes and Metabolism Journal

  • 제42권6호
  • /
  • Pages.538-543
  • /
  • 2018
  • /
  • 2233-6079(pISSN)
  • /
  • 2233-6087(eISSN)
대한당뇨병학회 (Korean Diabetes Association)
권호 표지
DOI QR코드

DOI QR Code

The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran

  • Ghaem, Haleh (Research Center for Health Sciences, Institute of Health, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences) ;
  • Daneshi, Nima (Behbahan Faculty of Medical Sciences) ;
  • Riahi, Shirin (Non-Communicable Diseases Research Center, Alborz University of Medical Sciences) ;
  • Dianatinasab, Mostafa (Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences)
  • 투고 : 2018.03.19
  • 심사 : 2018.04.26
  • 발행 : 2018.12.30
⟨ 이전 논문 다음 논문 ⟩

초록

Globally, diabetic retinopathy (DR) is one of the leading causes of blindness, that diminishes quality of life. This study aimed to describe the prevalence of DR, and its associated risk factors. This cross-sectional study was carried out among 478 diabetic patients in a referral center in Fars province, Iran. The mean${\pm}$standard deviation age of the participants was $56.64{\pm}12.45$ years old and DR prevalence was 32.8%. In multivariable analysis, lower education levels (adjusted odds ratio [aOR], 0.43; 95% confidence interval [CI], 0.24 to 0.76), being overweight (aOR, 1.70; 95% CI, 1.02 to 2.83) or obese (aOR, 1.88; 95% CI, 1.09 to 3.26), diabetes duration of 10 to 20 years (aOR, 2.35; 95% CI, 1.48 to 3.73) and over 20 years (aOR, 5.63; 95% CI, 2.97 to 10.68), receiving insulin (aOR, 1.99; 95% CI, 1.27 to 3.10), and having chronic diseases (aOR, 1.71; 95% CI, 1.02 to 2.85) were significantly associated with DR. In conclusion, longer diabetes duration and obesity or having chronic diseases are strongly associated with DR suggesting that control of these risk factors may reduce both the prevalence and impact of retinopathy in Iran.

키워드

과제정보

연구 과제 주관 기관 : Shiraz University of Medical Sciences

참고문헌

  1. Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol 2008;8:10. https://doi.org/10.1186/1471-2415-8-10
  2. Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, Lamoureux EL. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci 2012;53:677-84. https://doi.org/10.1167/iovs.11-8992
  3. Babazadeh T, Dianatinasab M, Daemi A, Nikbakht HA, Moradi F, Ghaffari-Fam S. Association of self-care behaviors and quality of life among patients with type 2 diabetes mellitus: Chaldoran County, Iran. Diabetes Metab J 2017;41:449-56. https://doi.org/10.4093/dmj.2017.41.6.449
  4. Al-Maskari F, El-Sadig M. Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol 2007;7:11. https://doi.org/10.1186/1471-2415-7-11
  5. Javadi MA, Katibeh M, Rafati N, Dehghan MH, Zayeri F, Yaseri M, Sehat M, Ahmadieh H. Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol 2009;9:12. https://doi.org/10.1186/1471-2415-9-12
  6. Santos-Bueso E, Fernandez-Perez C, Macarro A, Fernandez-Vigo J. Prevalence of diabetic retinopathy in the city of Badajoz 2002 (Extremadura project to prevent blindness). Arch Soc Esp Oftalmol 2007;82:153-8.
  7. Hu Y, Teng W, Liu L, Chen K, Liu L, Hua R, Chen J, Zhou Y, Chen L. Prevalence and risk factors of diabetes and diabetic retinopathy in Liaoning province, China: a population-based cross-sectional study. PLoS One 2015;10:e0121477. https://doi.org/10.1371/journal.pone.0121477
  8. Shrestha MK, Paudyal G, Wagle RR, Gurung R, Ruit S, Onta SR. Prevalence of and factors associated with diabetic retinopathy among diabetics in Nepal: a hospital based study. Nepal Med Coll J 2007;9:225-9.
  9. Dianatinasab M, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M, Rezaianzadeh A. Hair coloring, stress, and smoking increase the risk of breast cancer: a case-control study. Clin Breast Cancer 2017;17:650-9. https://doi.org/10.1016/j.clbc.2017.04.012
  10. Watkins PJ. Diabetes and its management. 6th ed. Oxford: Blackwell Publishing; 2003. Chapter 11, Management of diabetes during surgery and other illnesses; p95-103.
  11. Khatib OMN; World Health Organization. Guidelines for the prevention, management and care of diabetes mellitus. Cairo: World Health Organization; 2006.
  12. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
  13. Giloyan A, Harutyunyan T, Petrosyan V. The prevalence of and major risk factors associated with diabetic retinopathy in Gegharkunik province of Armenia: cross-sectional study. BMC Ophthalmol 2015;15:46. https://doi.org/10.1186/s12886-015-0032-0
  14. Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. Br J Ophthalmol 2002;86:1014-8. https://doi.org/10.1136/bjo.86.9.1014
  15. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BE, Klein R. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304:649-56. https://doi.org/10.1001/jama.2010.1111
  16. Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, Lim SC, Tai ES, Mitchell P. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008;115:1869-75. https://doi.org/10.1016/j.ophtha.2008.05.014
  17. Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL, North RV, Gibbins RL, Owens DR. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 2012;344:e874. https://doi.org/10.1136/bmj.e874
  18. Schillinger D, Grumbach K, Piette J, Wang F, Osmond D, Daher C, Palacios J, Sullivan GD, Bindman AB. Association of health literacy with diabetes outcomes. JAMA 2002;288:475-82. https://doi.org/10.1001/jama.288.4.475
  19. Dirani M, Xie J, Fenwick E, Benarous R, Rees G, Wong TY, Lamoureux EL. Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci 2011;52:4416-21. https://doi.org/10.1167/iovs.11-7208
  20. McKay R, McCarty CA, Taylor HR. Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. Br J Ophthalmol 2000;84:865-70. https://doi.org/10.1136/bjo.84.8.865

피인용 문헌

  1. Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study vol.43, pp.5, 2018, https://doi.org/10.4093/dmj.2018.0137